Feedback and Psychotherapeutic Competencies

March 19, 2015 updated by: Florian Weck, Goethe University

Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial

The purpose of the current study is to examine the influence of feedback on psychotherapeutic competency. The present randomized controlled study compares a feedback condition with a non-feedback condition. Therapists in the feedback condition receive feedback after every fourth session. The feedback is given by two trained and independent raters. The raters are licenced and experienced psychotherapists. Therapists in the non-feedback condition receive no feedback during the psychotherapy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hessen
      • Frankfurt/ Main, Hessen, Germany, 60486
        • Department of Clinical Psychology and Psychotherapy of Goethe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Therapists

Inclusion Criteria:

  • Having successfully completed the interim audit
  • Having started to treat ambulant patients
  • Remaining at least 6 month in the ambulance

Exclusion Criteria:

-

Patients

Inclusion Criteria:

  • Meeting ICD 10 criteria for a mental disorder
  • Informed consent

Exclusion Criteria:

  • Currently in psychotherapy
  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
  • Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feedback
Therapists assigned to this group will receive standardized feedback on their psychotherapeutic competency after every fourth treatment session with a patient for a period of 20 therapy sessions. The feedback will be given by two experienced raters who are licensed as psychological psychotherapists.
Experimental: No feedback
Therapists assigned to this group will receive no feedback
Therapists will receive no feedback.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Therapy Scale (CTS)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session. CTS will be used by two trained raters licensed as psychological psychotherapists.
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Helping Alliance Questionaire (HAQ)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess therapeutic alliance from the therapists perspective (therapist version; HAQ-T) and the patients perspective (HAQ-P)
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Berner Stundenbögen Version 2000
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess therapeutic relationship from the therapists perspective (therapist version, TSTB) and the patients perspective (patient version; PSTB)
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Global Assessment of Functioning (GAF)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
external measure to assess the global functioning of the patient
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Supervisory Questionaire (SQ)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess the therapists self-opening
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Supervisee Levels Questionaire (SLQ-R)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess the therapists self-awareness
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Counseling Self-Estimate Inventory (COSE)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess self efficacy of the therapist
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Fear of negative evaluation scale (Skala Angst vor negativer Bewertung; SANB)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess fear of evaluation
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Brief Symptom Inventory (BSI)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess aspects of general psychopathology
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Beck Depression Inventory II (BDI II)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess depressive symptoms
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Beck Anxiety Inventory (BAI)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess anxiety symptoms
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Client Satisfaction Questionaire (CSQ8)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess satisfaction with therapy
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
Health-related quality of life (SF-12)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
self-report measure to assess health-related quality of life
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

November 11, 2013

First Submitted That Met QC Criteria

November 11, 2013

First Posted (Estimate)

November 18, 2013

Study Record Updates

Last Update Posted (Estimate)

March 20, 2015

Last Update Submitted That Met QC Criteria

March 19, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Feedback-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Disorders

Clinical Trials on Feedback after every fourth session

Subscribe